Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
Rarecells has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
Rarecells's investors include Globivest, AA Sons.
Rarecells is headquartered in Paris, France.
Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
Rarecells is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rarecells — Funding & Investors." VCBacked, December 9, 2021, https://www.vcbacked.co/company/rarecells. Accessed September 12, 2026.
VCBacked. (2021). Rarecells — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/rarecells
{{cite web |title=Rarecells — Funding & Investors |url=https://www.vcbacked.co/company/rarecells |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated